LYON, France, March 9, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and full-year ended December 31, 2022, before the markets open on Thursday, March 30 th ,

Company to host conference call and webcast on Wednesday, March 27 th at 8:30am EDT LYON, France, March 13, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that it will release its financial results for the fourth quarter and

Joint Cooperation With Epitarget AS and INSERM to Improve Delivery of Cancer Drugs With HIFU

Agreement With Epitarget AS and INSERM

Strengthens its Leadership in Stone and Prostate Management

LYON, France , Jan. 23, 2017 (GLOBE NEWSWIRE) -- EDAP TMS SA (NASDAQ:EDAP), the global leader in therapeutic ultrasound, announced today that it has signed an exclusive agreement with the Canadian company LABORIE to distribute their urodynamic diagnostic products in Japan , one of the largest

Validates EDAP's Leadership in Urodynamics on the Territory

Launch of Ablatherm-HIFU Patient Database '@-REGISTRY'

Conference Call and Webcast Scheduled for 8:30 a.m. ET

Conference Call and Webcast Scheduled for 8:30 a.m. ET